Clinical Trial Update: Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nivolumab and epacadostat plus platinum doublet chemotherapy versus platinum doublet chemotherapy in non-small cell lung cancer; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Epacadostat (epacadostat)
• nivolumab (nivolumab)

Snippet

Sponsor: Incyte Corporation | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2019-06-13